1369 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Shah
    Shah
  4. Sauter
    Sauter
  5. Palomba
    Palomba
  6. Goldberg
    Goldberg
  7. Halton
    Halton
  8. Brentjens
    Brentjens
  9. Chen
    Chen
  10. Moskowitz
    Moskowitz

Groups

  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)
  7. Hematologic Malignancies, Division of (327)
  8. Solid Tumor Oncology Division (324)
  9. Population Sciences Research Program (261)
  10. Biostatistics Service (257)
  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (694)
  2. Journal Article (538)
  3. Review (51)
  4. Book Section (36)
  5. Editorial (16)
  6. Research Letter (14)
  7. Miscellaneous (10)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)

More Groups

People
  1. Sergio Giralt (98)
  2. Miguel-Angel Perales (77)
  3. Gunjan Shah (68)
  4. Sean Devlin (68)
  5. Craig Sauter (63)
  6. Maria Palomba (61)

More People

Years
  1. 2025 (29)
  2. 2024 (103)
  3. 2023 (92)
  4. 2022 (114)
  5. 2021 (101)
  6. 2020 (101)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Oncology Nursing Forum (117)
  3. Blood (114)
  4. Biology of Blood and Marrow Transplantation (59)
  5. Clinical Journal of Oncology Nursing (47)
  6. Annals of Surgical Oncology (36)

More Publications

Publishers
  1. American Society of Clinical Oncology (192)
  2. Elsevier Inc. (190)
  3. Oncology Nursing Society (ONS) (169)
  4. American Society of Hematology (121)
  5. Lippincott Williams & Wilkins (91)
  6. Springer (70)

More Publishers

Results (1369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts)
    Meeting Abstract

    Feldman, D. R.; Jacobsen, E. P.; Woo, K.; Steingart, R.; Fleisher, M.; Patil, S.; Carousso, M.; Laguerre, S.; Morales, T. D.; Sheinfeld, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170)
    Meeting Abstract

    Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning
    Meeting Abstract

    Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y. J.; Yoo, S.; Purdon, T.; Halton, E.; Quintanilla, H.; Curran, K. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Rapid response team triggers and outcomes in adult medical and surgical oncology patients
    Meeting Abstract

    Tayban, Y.; D'Agostino, R.; Pastores, S.; Halpern, N.
    Critical Care Medicine (2014)

    Fulltext@MSK | Save
  • Palliative care consultation and end-of-life care in an oncologic ICU
    Meeting Abstract

    Freise, C.; Wiesenthal, A.; Canecchia, L.; Lee, I.; Kostelecky, N.; Voigt, L.; Pastores, S.; Halpern, N.
    Critical Care Medicine (2014)

    Fulltext@MSK | Save
  • Staffing concerns with advanced practice providers in the ICU: Startling facts
    Meeting Abstract

    D'Agostino, R.; Halpern, N.; Pastores, S.; Yohannes-Tomicich, J.
    Critical Care Medicine (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save